Skip to content
Abierto
Menu

Special notice

NOI for InvivoScribe IGH+IGK Clonality Mega-ABI Assays

75N91026Q00007

Office of the Assistant Secretary for Administration (Asa), Office of the Assistant Secretary for Administration (Asa). In-Vitro Diagnostic Substance Manufacturing.

View on SAM.govMarkdown

Awarded

Invivoscribe, Inc.

$57,435.00 obligated so far on USAspending

Description

As published on SAM.gov.

NOTICE OF INTENT TO AWARD SOLE SOURCE THIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. This is a notice of intent to solicit and award a sole source contract under statutory authority 10 USC 2304(c)(1), set forth in Federal Acquisition Regulation 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The Government intends to solicit and award a sole source contract for InvivoScribe IGH+IGK Clonality Mega-ABI Assays to InvivoScribe. InvivoScribe is currently the only provider that carries the specific required IGH/ IGK kit that fits the need of NCI's molecular laboratories servicing the many protocols of the Clinical Center.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Invivoscribe, Inc.
UEI
R1EVMK8MEZS9
CAGE
455H0
Vendor location
San Diego, CA
Contract
75N91026P00014, purchase order
Obligated
$57,435.00
Actions
1 between March 4, 2026 and March 4, 2026
Competition
Not Competed, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Purchase of Invivoscribe Igh +igk B-Cell Clonality Assays
Match
solicitation number 75N91026Q00007 equals the FPDS solicitation identifier; awarding office not confirmed (medium confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. February 12, 2026

    Special notice

    Due February 17, 2026 at 12:00 PM EST. SAM.gov, notice 8881351daedd45aca120d8e52c4a5f59

Points of contact